Why responding to site-neutral payment risk is imperative for hospitals and health systems
As the likelihood of site-neutral payments increases over a range of services, hospitals and health systems must understand which services are most at risk from these changes and determine how quickly they will respond.
Provider conduct could have a big impact on the future of telehealth, experts say
Widespread certification for telehealth could encourage policymakers to retain the waivers that have promoted expanded virtual access, industry experts say.
Study: In price negotiations with hospitals, self-insured employers lack leverage
The vast difference in market power between hospitals and employers leaves the latter group with little recourse in negotiations, according to a new study.
Hospital care at home signifies an important innovation in acute care delivery
Although the CMS Acute Hospital Care at Home program is still early in its development in the U.S., early adopters show evidence of the program’s exciting promise, including positive impacts on health outcomes, an improved patient and provider experience, reduced cost of care and overall healthcare savings.
Moving a 340B covered entity’s pharmacy enterprise to an LLC may prove beneficial, but it requires a feasibility study
University of Utah Hospitals and Clinics (UUHC) in Salt Lake City performed research to assess the feasibility of moving its 340B covered-entity pharmacy enterprise to a Limited Liability Corporation (LLC), with a focus on risks that should be factored into the decision. Other organizations that are considering such a move could benefit from adopting UUHC’s assessment approach.
Healthcare News of Note: Few consumers are using publicly posted negotiated prices to comparison shop for healthcare services
Healthcare News of Note for healthcare finance professionals is a roundup of recent news articles: Little use of price transparency information to comparison shop for healthcare services, the nursing shortage being felt throughout the U.S., and cash payers being charged more for the same services than patients with insurance.
Medicare should update its policies for separately payable drugs in the Outpatient Prospective Payment System, MedPAC says
Worthwhile changes include requiring drugs to be proven clinically superior before granting them pass-through payment status, according to a new report.
The state of the 340B program: What the Supreme Court’s Affordable Care Act ruling meant, and which issues still loom
An under-the-radar aspect of the Supreme Court’s ruling on the Affordable Care Act involved hospital eligibility for the 340B program, an industry expert says.
MedPAC report: Cost-based reimbursement isn’t an ideal way to sustain rural hospitals
An extensive healthcare policy report by the Medicare Payment and Advisory Commission includes a discussion about the drawbacks of cost-based Medicare reimbursement for rural hospitals.
6 takeaways from HFMA’s Cost Effectiveness of Health Summit: Why health spending must become more cost-effective
HFMA’s first Cost Effectiveness of Health Summit drove home the urgency of improving how healthcare dollars are spent.